Why Im Not Arbing The Fresenius Akorn Deal | Latest News RSS feed

Why Im Not Arbing The Fresenius Akorn Deal - Latest News


Why I'm Not Arbing The Fresenius / Akorn Deal

Shares of Akorn have declined on no real news this week other than an analyst rumor that Fresenius could abandon its deal The no news move has me worried due to the no news moves on the way up Akorn ... read more

Selling Your Business Later: 5 Must-Do's Now

She told the IRS absolutely nothing about that second cash register—not about ... testing data. Fresenius walked away, although Akorn fought it. Akorn’s stock plunged when a court upheld Fresenius’ ... read more

Fresenius dumps its $4.3B Akorn buyout, and a 'legal battle royale' could come next

Akorn has its own argument, of course. The investigation “has not found any ... It’s easy to see why Fresenius might want out; the deal “math has clearly changed,” Stanicky noted, adding that Akorn is ... read more

Looking for another news?


Akorn FDA Report Added To Fresenius Trial Record

Travis Laster rejected a request by Akorn to close the courtroom for the hearing, noting the proceeding was likely "anticlimatic" as not many details would be discussed. However, the vice chancellor ... read more


Do We Have a Deal? A Groundbreaking Court Decision May Impact MAE Issues

Businesses pursuing a merger or acquisition transaction may want to consider the important issues of material adverse effect (MAE) presented in the recent decision of Akorn, Inc. v. Fresenius Kabi AG. ... read more

Fresenius Medical Care (FMS) Q1 2019 Earnings Call Transcript

I'm happy ... we're not revising our estimate for NxStage, but I'd expect something in the kind of mid-single digits in terms of revenue growth off the new adjusted base excluding Fresenius Medical ... read more

Revisiting Akorn: Huge Earnings Upside Amidst Quality Risks

Akorn Pharmaceuticals has been a wild ride over the past few years. Fresenius nixed its acquisition agreement and sent shares down below $3. I think the company has substantial earnings ... the time ... read more

How long before Baxter has to make a giant acquisition?

Becton Dickinson struck a $24 billion deal to purchase C.R. Bard, Fresenius SE agreed to pay $4.3 billion for Lake Forest's Akorn and Cardinal Health is ... medical products supplier Covidien. I'm ... read more

America’s love affair with cheap drugs has a hidden cost

Last month, the Delaware Supreme Court permitted the German company Fresenius SE to back out of its $4.3 billion takeover of Lake Forest, Illinois-based Akorn ... “not adequate,” though the reasons ... read more

This Market Needs the FAANGs to Perform, Or Else: Taking Stock

some M&A shifts (another utility deal in Vectren/CenterPoint Energy and the collapse of the $4.3 billion Akorn/Fresenius deal), and earnings, with UBS getting whacked in Zurich, Philips rallying in ... read more

America’s Love for Cheap Drugs Has a Hidden Cost

Last month, the Delaware Supreme Court permitted the German company Fresenius SE to back out of its $4.3bn takeover of Lake Forest, Illinois-based Akorn ... “not adequate,” though the reasons why are ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us